Metraipolis › archive › dc_df3ea150cfde

Anti-IgLON5 disease presenting with myokymia and favourable response to FcRN-antagonist combined with oral glucocorticoids: case report — Europe PMC PMID:42445184

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/42445184
DOI: 10.3389/fimmu.2026.1841316
License (as archived): solo-consultazione
Archived: 2026-10-31T07:08:09.196Z
SHA-256 of the archived text: 90eac36d347aa618ca9391ef9b91248c7ec79bb00c9f7d4616de4d63c7f9a5b1
Stable URL of this page: https://metraipolis.com/documento/dc_df3ea150cfde

How to cite

Anti-IgLON5 disease presenting with myokymia and favourable response to FcRN-antagonist combined with oral glucocorticoids: case report — Europe PMC PMID:42445184 — Europe PMC (en), https://europepmc.org/article/MED/42445184 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_df3ea150cfde (Metraipolis archive dc_df3ea150cfde, sha256 90eac36d347aa618ca9391ef9b91248c7ec79bb00c9f7d4616de4d63c7f9a5b1)

BibTeX

@misc{dcdf3ea150cfde,
  title = {Anti-IgLON5 disease presenting with myokymia and favourable response to FcRN-antagonist combined with oral glucocorticoids: case report — Europe PMC PMID:42445184},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42445184},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_df3ea150cfde; sha256 90eac36d347aa618ca9391ef9b91248c7ec79bb00c9f7d4616de4d63c7f9a5b1},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42445184. Agents can read the archived copy with the MCP tool read_document.